39158617|t|Empagliflozin-activated AMPK elicits neuroprotective properties in reserpine-induced depression via regulating dynamics of hippocampal autophagy/inflammation and PKCzeta-mediated neurogenesis.
39158617|a|RATIONALE: Major depression has been an area of extensive research during the last decades, for it represents a leading cause of disability and suicide. The stark rise of depression rates influenced by life stressors, economic threats, pandemic era, and resistance to classical treatments, has made the disorder rather challenging. Adult hippocampal neurogenesis and plasticity are particularly sensitive to the dynamic interplay between autophagy and inflammation. In fact, the intricate balance between the two processes contributes to neuronal homeostasis and survival. OBJECTIVES: Having demonstrated promising potentials in AMPK activation, a major metabolic sensor and autophagy regulator, empagliflozin (Empa) was investigated for possible antidepressant properties in the reserpine rat model of depression. RESULTS: While the reserpine protocol elicited behavioral, biochemical, and histopathological changes relevant to depression, Empa outstandingly hindered these pathological perturbations. Importantly, hippocampal autophagic response markedly declined with reserpine which disrupted the AMPK/mTOR/Beclin1/LC3B machinery and, conversely, neuro-inflammation prevailed under the influence of the NLRP3 inflammasome together with oxidative/nitrative stress. Consequently, AMPK-mediated neurotrophins secretion obviously deteriorated through PKCzeta/NF-kappaB/BDNF/CREB signal restriction. Empa restored hippocampal monoamines and autophagy/inflammation balance, driven by AMPK activation. By promoting the atypical PKCzeta phosphorylation (Thr403) which subsequently phosphorylates NF-kappaB at Ser311, AMPK successfully reinforced BDNF/CREB signal and hippocampal neuroplasticity. The latter finding was supported by hippocampal CA3 toluidine blue staining to reveal intact neurons. CONCLUSION: The current study highlights an interesting role for Empa as a regulator of autophagic and inflammatory responses in the pathology of depression. The study also pinpoints an unusual contribution for NF-kappaB in neurotrophins secretion via AMPK/PKCzeta/NF-kappaB/BDNF/CREB signal transduction. Accordingly, Empa can have special benefits in diabetic patients with depressive symptoms. LIMITATIONS: The influence of p-NF-kappaB (Ser311) on NLRP3 inflammasome assembly and activation has not been investigated, which can represent an interesting point for further research.
39158617	0	13	Empagliflozin	Chemical	MESH:C570240
39158617	24	28	AMPK	Gene	78975
39158617	67	76	reserpine	Chemical	MESH:D012110
39158617	85	95	depression	Disease	MESH:D003866
39158617	145	157	inflammation	Disease	MESH:D007249
39158617	162	169	PKCzeta	Gene	5590
39158617	204	220	Major depression	Disease	MESH:D003865
39158617	322	332	disability	Disease	MESH:D009069
39158617	364	374	depression	Disease	MESH:D003866
39158617	645	657	inflammation	Disease	MESH:D007249
39158617	822	826	AMPK	Gene	78975
39158617	889	902	empagliflozin	Chemical	MESH:C570240
39158617	904	908	Empa	Chemical	MESH:C570240
39158617	973	982	reserpine	Chemical	MESH:D012110
39158617	983	986	rat	Species	10116
39158617	996	1006	depression	Disease	MESH:D003866
39158617	1027	1036	reserpine	Chemical	MESH:D012110
39158617	1122	1132	depression	Disease	MESH:D003866
39158617	1134	1138	Empa	Chemical	MESH:C570240
39158617	1264	1273	reserpine	Chemical	MESH:D012110
39158617	1294	1298	AMPK	Gene	78975
39158617	1299	1303	mTOR	Gene	56718
39158617	1304	1311	Beclin1	Gene	114558
39158617	1344	1362	neuro-inflammation	Disease	MESH:D007249
39158617	1400	1405	NLRP3	Gene	287362
39158617	1475	1479	AMPK	Gene	78975
39158617	1544	1551	PKCzeta	Gene	5590
39158617	1552	1561	NF-kappaB	Gene	4790
39158617	1562	1566	BDNF	Gene	24225
39158617	1567	1571	CREB	Gene	81646
39158617	1592	1596	Empa	Chemical	MESH:C570240
39158617	1618	1628	monoamines	Chemical	-
39158617	1643	1655	inflammation	Disease	MESH:D007249
39158617	1675	1679	AMPK	Gene	78975
39158617	1718	1725	PKCzeta	Gene	5590
39158617	1785	1794	NF-kappaB	Gene	4790
39158617	1806	1810	AMPK	Gene	78975
39158617	1835	1839	BDNF	Gene	24225
39158617	1840	1844	CREB	Gene	81646
39158617	1937	1951	toluidine blue	Chemical	MESH:D014048
39158617	2052	2056	Empa	Chemical	MESH:C570240
39158617	2090	2102	inflammatory	Disease	MESH:D007249
39158617	2133	2143	depression	Disease	MESH:D003866
39158617	2198	2207	NF-kappaB	Gene	4790
39158617	2239	2243	AMPK	Gene	78975
39158617	2244	2251	PKCzeta	Gene	5590
39158617	2252	2261	NF-kappaB	Gene	4790
39158617	2262	2266	BDNF	Gene	627
39158617	2267	2271	CREB	Gene	81646
39158617	2306	2310	Empa	Chemical	MESH:C570240
39158617	2340	2348	diabetic	Disease	MESH:D003920
39158617	2349	2357	patients	Species	9606
39158617	2363	2382	depressive symptoms	Disease	MESH:D003866
39158617	2416	2425	NF-kappaB	Gene	4790
39158617	2438	2443	NLRP3	Gene	114548
39158617	Association	5590	81646
39158617	Association	MESH:D007249	78975
39158617	Positive_Correlation	MESH:C570240	78975
39158617	Negative_Correlation	MESH:C570240	MESH:D003866
39158617	Association	MESH:D012110	78975
39158617	Association	4790	81646
39158617	Association	627	78975
39158617	Association	MESH:D003866	4790
39158617	Association	24225	5590
39158617	Association	MESH:D007249	287362
39158617	Negative_Correlation	MESH:C570240	MESH:D003920
39158617	Association	4790	627
39158617	Association	MESH:C570240	4790
39158617	Association	24225	4790
39158617	Association	MESH:D012110	114558
39158617	Association	MESH:C570240	5590
39158617	Association	MESH:D007249	4790
39158617	Association	MESH:D012110	56718
39158617	Association	4790	78975
39158617	Association	4790	5590
39158617	Association	5590	78975
39158617	Positive_Correlation	MESH:D012110	MESH:D003866
39158617	Positive_Correlation	78975	81646
39158617	Association	24225	78975
39158617	Association	MESH:C570240	MESH:D007249
39158617	Association	114548	4790

